.svg){kind=small}
Dr. Jorg Taubel will be attending the AGAH Annual Meeting. As a pivotal event in the field of clinical pharmacology, the AGAH Annual Meeting brings together experts and professionals from around the world.
Since 1999, these gatherings have been a cornerstone of collaboration with esteemed international partner organisations, including the American College of Clinical Pharmacology (ACCP), the French Club Phase 1, the Belgian Association of Phase-1 Units (BAPU), and the British Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI).
Dr. Taubel's participation underscores our commitment to advancing knowledge and fostering collaboration in clinical pharmacology.
To find out more: https://www.agah.eu/events/annual-meetings/
-min.jpg)
.jpg)
Latest news
Recruiting breastfeeding mothers into clinical trials through transparent and sensitive conversations
April 30, 2024
Richmond Pharmacology's study on merotocin showed low transfer to breast milk, overcoming recruitment challenges through proximity to a maternity ward.
Read moreAnnouncement of Jorg Becoming President Elect
April 22, 2024
Richmond Pharmacology announces CEO Dr. Jorg Taubel's appointment as President Elect of Germany's AGAH, where he will enhance early-phase clinical research over a six-year term.
Read moreEvents
AHA Hypertension Scientific Sessions 2024
5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event
